130 related articles for article (PubMed ID: 9675784)
1. Hepatitis C in blood transfusion recipients identified at the Oxford Blood Centre in the national HCV look-back programme.
Dike AE; Christie JM; Kurtz JB; Teo CG
Transfus Med; 1998 Jun; 8(2):87-95. PubMed ID: 9675784
[TBL] [Abstract][Full Text] [Related]
2. Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C.
O'Riordan JM; Conroy A; Nourse C; Yap PL; McDonald GS; Kaminski G; Leong K; Lawlor E; Davoren A; Strong K; Davidson F; Lloyd A; Power J
Transfus Med; 1998 Dec; 8(4):303-8. PubMed ID: 9881424
[TBL] [Abstract][Full Text] [Related]
3. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
[TBL] [Abstract][Full Text] [Related]
4. Outcome of post-transfusion hepatitis C: disease severity in blood-component recipients and their implicated donors.
Smith BC; Chapman CE; Burt AD; Toms GL; Bassendine MF
QJM; 1997 Sep; 90(9):587-92. PubMed ID: 9349451
[TBL] [Abstract][Full Text] [Related]
5. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
[TBL] [Abstract][Full Text] [Related]
6. Transfusion-acquired hepatitis C: the Danish lookback experience. The Danish HCV [hepatitis C virus] Lookback Group.
Christensen PB; Groenbaek K; Krarup HB
Transfusion; 1999 Feb; 39(2):188-93. PubMed ID: 10037130
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C lookback programme: a single hospital experience.
Pawson R; Rajan S; Hazlehurst G; Dusheiko G; Miller R; Hewitt P; Mehta A
Transfus Med; 1999 Sep; 9(3):189-93. PubMed ID: 10555811
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus (HCV) RNA among anti-HCV-positive blood donors and their recipients.
Skaug K; Li H; Jonassen TO; Larsen J; Figenschau KJ
Vox Sang; 1993; 64(4):215-9. PubMed ID: 7685969
[TBL] [Abstract][Full Text] [Related]
9. Transfusion transmission of HCV infection before anti-HCV testing of blood donations in England: results of the national HCV lookback program.
Transfusion; 2002 Sep; 42(9):1146-53. PubMed ID: 12430671
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus transmission, 1988-1991, via blood components from donors subsequently found to be anti-HCV-positive.
Foberg U; Ekermo B; Widell A; Mathiesen U; Fryden A
Scand J Infect Dis; 1996; 28(1):21-6. PubMed ID: 9122627
[TBL] [Abstract][Full Text] [Related]
11. Transmission of hepatitis C virus by transfusion in Orebro County, Sweden, 1990-1992.
Norda R; Duberg AS; Sönnerborg A; Olcén P
Scand J Infect Dis; 1995; 27(5):449-52. PubMed ID: 8588133
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
[TBL] [Abstract][Full Text] [Related]
13. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease.
Alter HJ; Nakatsuji Y; Melpolder J; Wages J; Wesley R; Shih JW; Kim JP
N Engl J Med; 1997 Mar; 336(11):747-54. PubMed ID: 9052652
[TBL] [Abstract][Full Text] [Related]
14. [Hepatitis C virus (HCV) status in recipients transfused with blood from anti-HCV-positive donors].
Riisom K; Møller A
Ugeskr Laeger; 1998 Mar; 160(11):1637-9. PubMed ID: 9522657
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trial.
González A; Esteban JI; Madoz P; Viladomiu L; Genesca J; Muñiz E; Enríquez J; Torras X; Hernández JM; Quer J
Hepatology; 1995 Aug; 22(2):439-45. PubMed ID: 7635410
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus genotypes among blood donors and their recipients in Iceland determined by the polymerase chain reaction.
Löve A; Smáradóttir A; Thorsteinsson SB; Stanzeit B; Widell A
Vox Sang; 1995; 69(1):18-22. PubMed ID: 7483487
[TBL] [Abstract][Full Text] [Related]
17. Impact of screening blood donors for hepatitis C antibody on posttransfusion hepatitis: a prospective study with a second-generation anti-hepatitis C virus assay.
Huang YY; Yang SS; Wu CH; Shih WS; Huang CS; Chen PH; Lin YM; Shen CT; Chen DS
Transfusion; 1994 Aug; 34(8):661-5. PubMed ID: 7521077
[TBL] [Abstract][Full Text] [Related]
18. Use of hepatitis B core antibody-positive liver allograft in hepatitis C virus-positive and -negative recipients with use of short course of hepatitis B immunoglobulin and Lamivudine.
Jain A; Orloff M; Abt P; Kashyap R; Mohanka R; Lansing K; Kelley M; Bozorgzadeh A
Transplant Proc; 2005 Sep; 37(7):3187-9. PubMed ID: 16213345
[TBL] [Abstract][Full Text] [Related]
19. Look-back of anti-HCV ELISA-positive, HCV-RNA PCR-negative donors and recipients of their blood products.
Vrielink H; Reésink HW; Zaaijer HL; Scholten E; Kremer LC; Cuypers HT; Lelie PN; van Oers MH; van der Poel CL
Vox Sang; 1997; 72(2):67-70. PubMed ID: 9088071
[TBL] [Abstract][Full Text] [Related]
20. Transmission of HCV infection by RIBA indeterminate and positive blood units.
Kolho E; Naukkarinen R; Krusius T
Transfus Med; 1992 Sep; 2(3):243-8. PubMed ID: 1285012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
